Public Companies
Love Pharma: Bringing Psychedelic Therapies and Pharmaceutical Alternatives to Market
Love Pharma (CSE:LUV) has launched its campaign on the Investing News Network.
The post Love Pharma: Bringing Psychedelic Therapies and Pharmaceutical…

Love Pharma (CSE:LUV) creates innovative science-driven products to cater to the ever-evolving space of sexual health and wellness. The company was founded in 2020 and is on a mission to offer new and trustworthy products that make use of “new age” pharmaceuticals backed by thorough scientific research. Love Pharma will launch with products that focus on nutraceuticals, which are pharmaceutical alternatives that have naturally occurring benefits, such as CBD and THC. It will launch with two products: Bloom and Auralief. Additional products are already under development.
Love Pharma’s Company Highlights
- Love Pharma specializes in sexual health and wellness by distributing products infused with CBD and THC directly to consumers. It holds exclusive licenses to produce, market, package, sell and distribute these patent-protected products throughout North America, the United Kingdom and Europe.
- The company is investing in creating sustainable long-term sales through strategic distributor partnerships
- The launch products, Bloom and Auralief, are licensed for retail sales, creating an immediate opportunity for revenue
- Love Pharma has already planned domestic and international expansion
- The management team has an established history of success with cannabis and pharmaceutical products
- The company plans to create research-backed products that make use of psychedelics and nutraceuticals
- Once the company is publicly listed, plans are already in place to rapidly distribute products and quickly generate revenue

Continue Reading
-
Psilocybin16 hours ago
Psychedelics Could Disrupt the $42 Billion a Year Rehab Industry
-
Public Companies16 hours ago
Psychedelic Sector News – Weekly Extractions: August 5, 2022
-
Public Companies17 hours ago
Our First 3 Psychstocks Gained Avg of 392%!
-
Psilocybin14 hours ago
Pay-For-Success Contracts: An Open Source Alternative to Psychedelic Patents
-
Psychedelics17 hours ago
Aaron Rodgers goes deeper on ayahuasca retreat, family feud with NBC’s Peter King
-
Psilocybin15 hours ago
What Happens when Psychedelics Meets Video Games?
-
Public Companies15 hours ago
Biotech Co. Awakes To Good News
-
Psilocybin13 hours ago
Treating Opioid Addiction with Ibogaine – Could This Be the Future?